Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 349

1.

Public health. A sound rationale needed for phase III HIV-1 vaccine trials.

Burton DR, Desrosiers RC, Doms RW, Feinberg MB, Gallo RC, Hahn B, Hoxie JA, Hunter E, Korber B, Landay A, Lederman MM, Lieberman J, McCune JM, Moore JP, Nathanson N, Picker L, Richman D, Rinaldo C, Stevenson M, Watkins DI, Wolinsky SM, Zack JA.

Science. 2004 Jan 16;303(5656):316. No abstract available.

PMID:
14726576
2.

Policy rebuttal. HIV vaccine trial justified.

McNeil JG, Johnston MI, Birx DL, Tramont EC.

Science. 2004 Feb 13;303(5660):961. No abstract available.

PMID:
14963313
3.

Public health. AIDS vaccine still alive as booster after second failure in Thailand.

Cohen J.

Science. 2003 Nov 21;302(5649):1309-10. No abstract available.

PMID:
14631004
4.

HIV vaccines. Viral envelope fails to deliver?

Bolognesi DP, Matthews TJ.

Nature. 1998 Feb 12;391(6668):638-9. No abstract available.

PMID:
9490406
5.

Support for the RV144 HIV vaccine trial.

Belshe R, Franchini G, Girard MP, Gotch F, Kaleebu P, Marthas ML, McChesney MB, McCullough R, Mhalu F, Salmon-Ceron D, Sekaly RP, van Rompay K, Verrier B, Wahren B, Weissenbacher M.

Science. 2004 Jul 9;305(5681):177-80; author reply 177-80. No abstract available.

PMID:
15247455
6.

Thailand's Prime-Boost HIV Vaccine Phase III.

Trinvuthipong C.

Science. 2004 Feb 13;303(5660):954-5. No abstract available.

PMID:
14963308
7.

Support for the RV144 HIV vaccine trial.

AIDS Vaccine Advocacy Coalition.

Science. 2004 Jul 9;305(5681):177-80; author reply 177-80. No abstract available.

PMID:
15250069
8.

AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope.

Emini EA, Koff WC.

Science. 2004 Jun 25;304(5679):1913-4. No abstract available.

PMID:
15218131
9.

Outstanding questions on HIV vaccine trial.

Jefferys R, Harrington M.

Science. 2004 Jul 9;305(5681):180; author reply 180. No abstract available.

PMID:
15247456
10.

AIDS vaccines. Glimmerings of hope from the bottom of the well.

Cohen J.

Science. 1999 Jul 30;285(5428):656-7. No abstract available.

PMID:
10454914
11.

Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers.

Belshe RB, Stevens C, Gorse GJ, Buchbinder S, Weinhold K, Sheppard H, Stablein D, Self S, McNamara J, Frey S, Flores J, Excler JL, Klein M, Habib RE, Duliege AM, Harro C, Corey L, Keefer M, Mulligan M, Wright P, Celum C, Judson F, Mayer K, McKirnan D, Marmor M, Woody G; National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group and HIV Network for Prevention Trials (HIVNET).

J Infect Dis. 2001 May 1;183(9):1343-52. Epub 2001 Apr 10.

PMID:
11294665
12.

Poxvirus vector-based HIV vaccines.

Pantaleo G, Esteban M, Jacobs B, Tartaglia J.

Curr Opin HIV AIDS. 2010 Sep;5(5):391-6. doi: 10.1097/COH.0b013e32833d1e87. Review.

PMID:
20978379
13.

Induction of neutralizing antibodies and cytotoxic T lymphocytes in Balb/c mice immunized with virus-like particles presenting a gp120 molecule from a HIV-1 isolate of clade A.

Buonaguro L, Racioppi L, Tornesello ML, Arra C, Visciano ML, Biryahwaho B, Sempala SD, Giraldo G, Buonaguro FM.

Antiviral Res. 2002 Jun;54(3):189-201.

PMID:
12062391
14.

AIDS research. Debate begins over new vaccine trials.

Cohen J.

Science. 2001 Sep 14;293(5537):1973. No abstract available.

PMID:
11557856
15.

Impending AIDS vaccine trial opens old wounds.

Balter M.

Science. 1998 Jan 30;279(5351):650. No abstract available.

PMID:
9471726
16.

Lessons from a multisite international trial in the Caribbean and South America of an HIV-1 Canarypox vaccine (ALVAC-HIV vCP1452) with or without boosting with MN rgp120.

Cleghorn F, Pape JW, Schechter M, Bartholomew C, Sanchez J, Jack N, Metch BJ, Hansen M, Allen M, Cao H, Montefiori DC, Tomaras GD, Gurunathan S, Eastman DJ, do Lago RF, Jean S, Lama JR, Lawrence DN, Wright PF; 026 Protocol Team and the NIAID HIV Vaccine Trials Network.

J Acquir Immune Defic Syndr. 2007 Oct 1;46(2):222-30.

PMID:
17693888
17.

The HIV vaccine pipeline, from preclinical to phase III.

Schultz AM, Bradac JA.

AIDS. 2001;15 Suppl 5:S147-58. Review. No abstract available.

PMID:
11816163
18.

HIV vaccine efficacy trials: towards the future of HIV prevention.

Kim D, Elizaga M, Duerr A.

Infect Dis Clin North Am. 2007 Mar;21(1):201-17, x.

PMID:
17502236
19.

HIV gp120 vaccine (Chiron).

[No authors listed]

Drugs R D. 1999 Jun;1(6):445-7. No abstract available.

PMID:
10566078
20.

Thailand weighs AIDS vaccine tests.

Cohen J.

Science. 1995 Nov 10;270(5238):904-7. No abstract available.

PMID:
7481784

Supplemental Content

Support Center